Ruffer’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Ruffer's NBIX Position: Q3 2026 in Review
Ruffer increased its Neurocrine Biosciences (NBIX) stake by 97% in Q3 2026, buying an estimated $5.38M and bringing the position to 68,039 shares worth $5.48M. The position accounts for 0.28% of the portfolio, ranked #92.
Ruffer first reported a position in NBIX in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.81M in Q2 2026. 630 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Ruffer held 68,039 shares of Neurocrine Biosciences worth $5.48M as of Q3 2026.
- Ruffer bought 33,498 Neurocrine Biosciences shares in Q3 2026, an estimated $5.38M.
- Neurocrine Biosciences made up 0.28% of Ruffer's portfolio in Q3 2026, its #92 holding.
- Ruffer first reported a position in Neurocrine Biosciences in Q4 2025 and has held it in 4 quarters since.
- Ruffer's Neurocrine Biosciences position peaked at $5.81M in Q2 2026.
- 630 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.